Important Dates
Early Bird Registration :7th September 2026
Paper Submission Deadline :12th September 2026
Last Date of Registration : 22nd September 2026
Date of Conference : 7th - 8th October 2026
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 16 — Peace, Justice and Strong Institutions
Track 01
Innovations in Psychopharmacological Treatments
This track will explore the latest advancements in psychopharmacological therapies for various psychiatric disorders. Emphasis will be placed on novel drug formulations and their clinical applications.
Track 02
Neuroscience of Mental Health Disorders
This session will delve into the neurobiological underpinnings of mental health conditions, highlighting how neuroscience informs psychopharmacological interventions. Researchers will present findings that bridge the gap between brain function and psychiatric treatment.
Track 03
Clinical Trials in Psychiatry
Focusing on the design and outcomes of clinical trials for psychiatric drugs, this track will discuss methodologies and ethical considerations in research. Participants will gain insights into the challenges and successes of bringing new therapies to market.
Track 04
Pharmacological Approaches to Emotional Wellbeing
This session will examine the role of pharmacotherapy in enhancing emotional wellbeing among patients with psychiatric disorders. Discussions will include the efficacy of various drug classes and their impact on quality of life.
Track 05
Behavioral Health and Psychopharmacology
This track will investigate the intersection of behavioral health and psychopharmacology, focusing on how medications can influence behavioral outcomes. Presentations will cover case studies and research findings that highlight this relationship.
Track 06
Advancements in Drug Therapy for Anxiety Disorders
This session will focus on the latest developments in pharmacological treatments for anxiety disorders, including both traditional and novel approaches. Experts will share insights into the effectiveness and safety profiles of emerging therapies.
Track 07
Integrative Approaches in Psychiatric Care
This track will explore integrative models that combine pharmacological and non-pharmacological interventions in psychiatric care. Participants will discuss the benefits and challenges of implementing such approaches in clinical practice.
Track 08
Psychiatric Research Methodologies
Focusing on innovative research methodologies in psychiatry, this session will cover both qualitative and quantitative approaches. Researchers will present their findings and discuss the implications for future psychopharmacological studies.
Track 09
Ethical Considerations in Psychopharmacology
This track will address the ethical dilemmas faced in psychopharmacological research and practice, including informed consent and the use of placebos. Discussions will aim to foster a deeper understanding of ethical standards in psychiatric care.
Track 10
Personalized Medicine in Psychiatry
This session will explore the concept of personalized medicine in the context of psychopharmacology, focusing on how genetic and environmental factors influence treatment responses. Presentations will highlight current research and future directions in tailored therapeutic strategies.
Track 11
Future Directions in Psychopharmacological Research
This track will provide a platform for discussing emerging trends and future directions in psychopharmacological research. Participants will explore innovative approaches and technologies that may shape the future of psychiatric treatments.